Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous T Cells With a Chimeric Antigen Receptor in Patients With CD19-positive Malignant B Cell Leukemia and Lymphoma

NCT02933775 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT02933775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous T Cells With a Chimeric Antigen Receptor in Patients With CD19-positive Malignant B Cell Leukemia and Lymphoma
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2016
Completion date
January 31, 2020
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cd19 positive malignant b-cell leukemia and lymphoma